Federal Grant Cuts have impacted PP405 related research    Technology 9/4/2025  
  Federal funding cuts have delayed PP405 research, affecting hair loss treatment progress, though clinical trials will continue. The discussion highlights PP405's potential compared to minoxidil and finasteride and stresses the importance of government-funded research. 
   View this post in the Community →
 Similar Community Posts Join
6 / 298 resultscommunity PP405 is a game changer. One for the history books. Era defining moment and Pelage know it.
 PP405 is a new hair loss treatment that may outperform minoxidil and finasteride by growing thick hair in bald areas within four weeks. Its release is expected around 2028, but concerns about its long-term efficacy and cost remain.  
 community The amazing fast pace of PP405.
 PP405 is a new hair loss treatment advancing quickly in trials, generating excitement and skepticism about its effectiveness and marketing claims. Some see it as a potential alternative to minoxidil and finasteride, but concerns about long-term effects and the need for DHT blockers persist.  
 community People are misunderstanding PP405. 31% response at 8 weeks is better than you think
 PP405 shows promise as a hair loss treatment, with 31% experiencing increased hair density in a short trial. It may complement treatments like finasteride and minoxidil, but long-term effectiveness and safety need confirmation.  
 community Please can someone explain all the Dutasteride horror stories on here
 Switching from finasteride to dutasteride for hair loss yields mixed results, with some users experiencing improvements and others facing worsening conditions or side effects like shedding. Patience is advised as dutasteride may take longer to show results, and combining treatments is suggested by some users.  
 community PP405 timeframe ? Could it replace current treatments ?
 PP405 is a potential new hair loss treatment that might replace finasteride and minoxidil, but it is still in clinical trials and may not be available until 2028-2031. There is skepticism about its effectiveness, with only a 20% increase in hair density observed in some participants.  
 community Today was Last update on pp405
 A new hair loss treatment, PP405, is moving from phase 2A to 2B in clinical trials, sparking discussions about its potential to regrow dormant hairs and its impact on existing treatments like Minoxidil and finasteride. Some users express skepticism, while others are hopeful about its future effectiveness.  
 Related Research
6 / 18 results 
  research Recent Advances in Drug Development for Hair Loss
 New treatments for hair loss show promise with advanced therapies and better targeting.  
  
  research Complementary and Alternative Medicine for Vitiligo
 Eat antioxidant-rich foods, reduce fast food, and explore various treatments for vitiligo.  
 research Moxibustion Improves Ovarian Function Based on the Regulation of the Androgen Balance
 Moxibustion may help improve ovarian function by changing androgen levels.  
  
  research Whole Neonatal Cochlear Explants as an In Vitro Model
 The new method makes it easier to study the whole cochlea from newborn mice and rats in the lab.  
  
  research Review of the 2024 American Academy of Dermatology Annual Meeting
 New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.  
  
  research Use of Vitamins and Minerals in the Treatment of Hair Loss: A Cross-Sectional Survey Among Dermatologists in Saudi Arabia
 Many dermatologists in Saudi Arabia recommend vitamins and minerals for hair loss, often based on personal experience rather than strong evidence.